RedHill Biopharma (RDHL) Receivables - Other (2022 - 2025)
RedHill Biopharma (RDHL) posted quarterly Receivables - Other of $3.1 million for Q4 2025, up 134.48% quarter-over-quarter from $1.3 million in Q2 2023.
RedHill Biopharma (RDHL) Receivables - Other (2022 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Receivables - Other for 3 consecutive years, with $3.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables - Other changed N/A year-over-year to $3.1 million; the TTM figure through Dec 2025 stood at $3.1 million (changed N/A YoY), while the FY2025 annual figure was $3.1 million, changed N/A from the prior year.
- Receivables - Other advanced to $3.1 million in Q4 2025 per RDHL's latest filing, from $1.3 million in the prior quarter.
- Across five years, Receivables - Other topped out at $3.1 million in Q4 2025 and bottomed at $1.3 million in Q2 2023.
- Historically, Receivables - Other has averaged $2.1 million across 3 years, with a median of $1.9 million in 2022.
- On a YoY basis, Receivables - Other climbed as much as 28.58% in 2023 and fell as far as 28.58% in 2023.
- RedHill Biopharma's Receivables - Other stood at $1.9 million in 2022, then declined by 28.58% to $1.3 million in 2023, then surged by 134.48% to $3.1 million in 2025.
- Business Quant data shows RDHL's Receivables - Other at $3.1 million in Q4 2025, $1.3 million in Q2 2023, and $1.9 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.14 Mn |
| Dec 31, 2025 | 3.14 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.34 Mn |
| Jun 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.87 Mn |